PRAVINCHANDRA PATEL: Open Payments
NPI 1083673958 · MARTINSVILLE, VA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$270 in 13 payments from 7 companies in 2025. Trend: 2023 $0 · 2024 $60 · 2025 $270
Food & beverage: $270
| Company | Payments | Amount |
|---|---|---|
| E.R. Squibb & Sons, L.L.C. | 3 | $77 |
| Neurocrine BioSciences, Inc. | 3 | $65 |
| Janssen Pharmaceuticals, Inc | 2 | $38 |
| Alkermes, Inc. | 2 | $35 |
| Otsuka America Pharmaceutical, Inc. | 1 | $19 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 1 | $18 |
| Vanda Pharmaceuticals Inc. | 1 | $18 |
Products named: COBENFY, INGREZZA, INVEGA SUSTENNA, ABILIFY MAINTENA, VIVITROL, CAPLYTA, FANAPT, ARISTADA.
Industry payments across VA — which companies pay providers there.
